Skip to main content
Clinical Trials/ACTRN12606000132549
ACTRN12606000132549
Completed
Phase 4

Randomised crossover trial of a porous haemodialysis membrane compared to a conventional high-flux membrane in stable haemodialysis patients to determine the short term impact on inflammatory and nutritional indices.

Fresenius0 sites30 target enrollmentApril 11, 2006

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Haemodialysis
Sponsor
Fresenius
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 11, 2006
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fresenius

Eligibility Criteria

Inclusion Criteria

  • Stable haemodialysis patients, currently dialysed with FX60 dialysers.

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials